The combination of type I interferon and ribavirin has an inhibitory effect on mouse hepatitis virus infection
スポンサーリンク
概要
- 論文の詳細を見る
- 2007-06-01
著者
-
TANABE Junichi
Pharmaceutical Research Laboratory, Toray Industries Inc.
-
Tanabe Junichi
Pharmaceutical Research Laboratory Toray Industries Inc.
-
TAGUCHI Fumihiro
National Institute of Infectious Diseases
-
Taguchi Fumihiro
National Institute Of Neuroscience Ncnp
-
SONE Saburo
Pharmaceutical Research Laboratory, Toray Industries Inc.
-
IZAWA Akiko
Pharmaceutical Research Laboratory, Toray Industries Inc.
-
NARUMI Hideki
Pharmaceutical Research Laboratory, Toray Industries Inc.
-
KAJITA Akemi
Kamakura Technoscience
-
Izawa Akiko
Pharmaceutical Research Laboratory Toray Industries Inc.
-
Narumi Hideki
Pharmaceutical Research Laboratory Toray Industries Inc.
-
Sone Saburo
Pharmaceutical Research Laboratory Toray Industries Inc.
関連論文
- Inflammatory cytokines modulate chemokine production patterns of HepG2 cells toward initially inclined direction
- Co-infection of respiratory bacterium with severe acute respiratory syndrome coronavirus induces an exacerbated pneumonia in mice
- The combination of type I interferon and ribavirin has an inhibitory effect on mouse hepatitis virus infection
- Neutralizing antibody against severe acute respiratory syndrome (SARS)-coronavirus spike is highly effective for the protection of mice in the murine SARS model